please supply a category in the pcf properties

Research

Diversity, Equity and Inclusion Research Grants Fund Eight New TTUHSC Initiatives

  • By Kate Gollahon
  • November 11, 2022

Eight teams within the TTUHSC community were chosen as recipients of research grants offered through the Office of DEI, in collaboration with the Office of Research and the Office of the Provost.

Research

Kang Receives CPRIT Funding to Support West Texas Pharmacology Core

  • By Mark Hendricks
  • November 09, 2022

CPRIT recently awarded a five-year, $3.37 million grant to Min Kang, Pharm.D. The grant will support the West Texas Pharmacology Core laboratory at TTUHSC.

Research

Collaborative Analysis Finds No Link Between COVID-19 Vaccines, Guillain Barre Syndrome

  • By Mark Hendricks
  • November 08, 2022

The collaborative team's study, “No significant increase in Guillain-Barré syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study,” was published in August 2022 by the journal Vaccine.

Research

Study Shows Shaker Channel Mutation Differs Structurally from Human Potassium Channels

  • By Mark Hendricks
  • October 12, 2022

In a study led by Luis Cuello, Ph.D., and Alain J. Labro, Ph.D., the researchers investigated whether or not a known mutation (W434F) found within Shaker-IR channel functionally accelerates the C-type inactivation state.

Research

Startups Begin Here! Four Startups Awarded $50,000 from TTUHSC President

  • By Kathryn Dankesreiter (TTU)
  • September 26, 2022

The Innovation Hub at Research Park today (September 26, 2022) announced the winners of its annual Presidents' Innovative Startup Awards. The award recognizes startups that have a high potential for growth and an economic impact in West Texas.

Research

TTUHSC Scientist Awarded U.S. Patent to Battle Antibiotic Resistance Using Novel Nanoantibiotics

  • By Mark Hendricks
  • September 01, 2022

Hongjun Liang, Ph.D., said infection poses a significant challenge for both frontline doctors and scientists alike. It’s a challenge he wants to be able to fight by using innovation to develop a new generation of antibiotics.

Research

Research Identifies, Exploits Vulnerability in Certain High-Risk Cancers

  • By Mark Hendricks
  • August 10, 2022

In a study recently published in Cancer Research, a team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director for the TTUHSC School of Medicine Cancer Center, sought to expand upon his lab’s previous research.

Research

Teaching an Old Drug New Tricks

  • By Mark Hendricks
  • July 27, 2022

Sanjay Srivastava, Ph.D., earned a U.S. patent for repurposing an antipsychotic drug to treat various types of cancer.

Research

Snail Fever Vaccine Reaches First Human Clinical Trial

  • By Kate Gollahon
  • June 10, 2022

A preventative vaccine for major tropical disease schistosomiasis has reached a Phase 1 clinical trial, providing a dose for the first healthy human volunteer.

Research

Gene Sequencing an Important Tool in COVID-19 Battle

  • By Mark Hendricks
  • June 09, 2022

Gene sequencing, a process of determining the sequential order of the building blocks that make up a strand of DNA, is used to keep pace with the constantly moving target that is COVID-19.

Tags